May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Advanced Glycation End- Products (AGEs) in the Anterior Chamber Angle of Patients With Glaucoma
L. E. Pillunat; V. Zubaty; E. Spoerl; A. G. Boehm; K. Geiger
Author Affiliations & Notes
  • L. E. Pillunat
    University of Dresden, Dresden, Germany
    Dept of Ophthalmology,
  • V. Zubaty
    University of Dresden, Dresden, Germany
    Dept of Ophthalmology,
  • E. Spoerl
    University of Dresden, Dresden, Germany
    Dept of Ophthalmology,
  • A. G. Boehm
    University of Dresden, Dresden, Germany
    Dept of Ophthalmology,
  • K. Geiger
    University of Dresden, Dresden, Germany
    Dept of Neuropathology,
  • Footnotes
    Commercial Relationships L.E. Pillunat, None; V. Zubaty, None; E. Spoerl, None; A.G. Boehm, None; K. Geiger, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 1147. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Advanced Glycation End- Products (AGEs) in the Anterior Chamber Angle of Patients With Glaucoma
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      L. E. Pillunat, V. Zubaty, E. Spoerl, A. G. Boehm, K. Geiger; Advanced Glycation End- Products (AGEs) in the Anterior Chamber Angle of Patients With Glaucoma. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1147.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose:: Oxidative stress facilitates the deposition of advanced glycation end-products (AGEs) which has been associated with age-related tissue alterations, neurodegenerative and diabetic pathology. In the eye, AGEs have been demonstrated in diabetic retinopathy and in the retina of glaucoma patients. Here, we studied an association of AGEs with alterations of the anterior chamber angle in glaucoma patients by immunohistochemistry.

Methods:: Immunohistochemistry (IHC) for the monoclonal anti-AGE- 6D12 was performed on sections of paraffin-embedded tissues of 26 trabeculectomy specimens from patients with POAG. For comparison, we studied 10 eyes of healthy corneal transplant donors within the same age group, and 12 eyes which had been enucleated because of secondary glaucoma. IHC was performed using the indirect alkaline phosphatase technique. The sections were evaluated in a masked fashion using a semiquantitative scoring system.

Results:: .The trabeculectomy specimens showed varying degrees of fibrosis and a fine pattern of regular dot-like AGE-deposits, (grades 1-2), which was more extensive in 4 cases (grade 3). Eyes with secondary glaucoma showed moderate to extensive deposits (grade 3-4) of AGEs within the anterior chamber angle mostly associated with the basis of the iris and the channel of Schlemm, but only small deposits (grade 1-2) in the superficial trabecular meshwork and in the sclera. In donor eyes the anterior chamber angle remained mostly free of AGEs and the extent of AGE-deposition in the retina was dependent on age.

Conclusions:: We have demonstrated the deposition of AGEs in the anterior chamber angle of patients with glaucoma. The observed pathology was more severe in cases with secondary glaucoma and unfavourable outcome. Our results support the assumption that some of the passage inhibition of aqueous humor in glaucoma may be related to the effects of advanced aging with the possible consequence of altered rigidity within the trabecular meshwork.

Keywords: trabecular meshwork • immunohistochemistry 
© 2007, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept